NATR Price / Book | NATURE’S SUNSHINE PRODUCTS, INC.

NATURES SUNSHINE PRODUCTS INC Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

NATURES SUNSHINE PRODUCTS INC price/book ratio for the quarter ending 2026-06-30 was 2.27, a 42.10% increase year-over-year.
NATURES SUNSHINE PRODUCTS INC price/book ratio for the quarter ending 2026-03-31 was 2.51, a 81.26% increase year-over-year.
NATURES SUNSHINE PRODUCTS INC price/book ratio for the quarter ending 2025-12-31 was 2.34, a 39.28% increase year-over-year.
NATURES SUNSHINE PRODUCTS INC price/book ratio for the quarter ending 2025-09-30 was 1.64, a 5.59% increase year-over-year.
NATURES SUNSHINE PRODUCTS INC price/book ratio for fiscal 2026 was 2.27.
NATURES SUNSHINE PRODUCTS INC price/book ratio for fiscal 2025 was 2.34, a 39.28% increase from fiscal 2024.
NATURES SUNSHINE PRODUCTS INC price/book ratio for fiscal 2024 was 1.68, a 17.72% decline from fiscal 2023.
NATURES SUNSHINE PRODUCTS INC price/book ratio for fiscal 2023 was 2.05, a 89.35% increase from fiscal 2022.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.27	$383.63M	$169.32M
2026-03-31	2.51	$419.78M	$166.92M
2025-12-31	2.34	$378.7M	$161.55M
2025-09-30	1.64	$272.71M	$166.7M
2025-06-30	1.59	$261M	$163.68M
2025-03-31	1.39	$231.85M	$167.1M
2024-12-31	1.68	$270.96M	$160.99M
2024-09-30	1.55	$251.94M	$162.62M
2024-06-30	1.78	$278.92M	$156.4M
2024-03-31	2.44	$390.19M	$159.71M
2023-12-31	2.05	$326.35M	$159.54M
2023-09-30	2.08	$316.44M	$152.01M
2023-06-30	1.74	$260.69M	$149.4M
2023-03-31	1.33	$194.45M	$146.72M
2022-12-31	1.08	$158.85M	$147.05M
2022-09-30	1.11	$157.93M	$141.75M
2022-06-30	1.42	$205.49M	$144.48M
2022-03-31	2.19	$327.33M	$149.78M
2021-12-31	2.26	$364.89M	$161.4M
2021-09-30	1.96	$289.7M	$147.63M
2021-06-30	2.36	$347.23M	$147.15M
2021-03-31	2.81	$397.5M	$141.5M
2020-12-31	1.87	$294.47M	$157.23M
2020-09-30	1.53	$226.68M	$148.24M
2020-06-30	1.26	$175.79M	$139.24M
2020-03-31	1.19	$158.29M	$132.57M
2019-12-31	1.34	$173.33M	$129.44M
2019-09-30	1.26	$160.25M	$126.77M
2019-06-30	1.44	$179.32M	$124.74M
2019-03-31	1.47	$179.05M	$122.02M
2018-12-31	1.3	$156.51M	$120.57M
2018-09-30	1.36	$168.04M	$123.49M
2018-06-30	1.47	$178.87M	$121.66M
2018-03-31	1.73	$209.51M	$121.01M
2018-01-01	1.83	$218.51M	$119.73M
2017-12-31	1.83	$218.51M	$119.73M
2017-09-30	1.41	$191.86M	$136.32M
2017-06-30	1.87	$250.33M	$133.68M
2017-03-31	1.41	$188.63M	$133.55M
2016-12-31	2.13	$281.36M	$132.4M
2016-09-30	2.11	$300.06M	$142.41M
2016-06-30	1.29	$178.66M	$138.62M
2016-03-31	1.31	$179.7M	$136.89M
2015-12-31	1.38	$188.11M	$136.27M
2015-09-30	1.66	$223.13M	$134.55M
2015-06-30	1.92	$258.27M	$134.21M
2015-03-31	1.85	$245.46M	$132.78M
2014-12-31	2.14	$276.57M	$128.96M
2014-09-30	2.05	$280.3M	$136.6M
2014-06-30	2.33	$274.96M	$118.2M
2014-03-31	1.95	$222.95M	$114.58M
2013-12-31	2.66	$280.22M	$105.26M
2013-09-30	2.94	$308.11M	$104.83M
2013-06-30	2.13	$260.98M	$122.77M
2013-03-31	2.04	$241.92M	$118.84M
2012-12-31	1.98	$228.93M	$115.64M
2012-09-30	2.3	$257.53M	$111.85M
2012-06-30	0	$235,695.90	$102.56M
2012-03-31	2.61	$249.94M	$95.79M
2011-12-31	2.76	$241.63M	$87.44M
2011-09-30	2.73	$219.18M	$80.39M
2011-06-30	3.63	$303.09M	$83.56M
2010-12-31	2.04	$139.49M	$68.38M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.27	$383.63M	$169.32M
2025-12-31	2.34	$378.7M	$161.55M
2024-12-31	1.68	$270.96M	$160.99M
2023-12-31	2.05	$326.35M	$159.54M
2022-12-31	1.08	$158.85M	$147.05M
2021-12-31	2.26	$364.89M	$161.4M
2020-12-31	1.87	$294.47M	$157.23M
2019-12-31	1.34	$173.33M	$129.44M
2018-12-31	1.3	$156.51M	$120.57M
2017-12-31	1.83	$218.51M	$119.73M
2016-12-31	2.13	$281.36M	$132.4M
2015-12-31	1.38	$188.11M	$136.27M
2014-12-31	2.14	$276.57M	$128.96M
2013-12-31	2.66	$280.22M	$105.26M
2012-12-31	1.98	$228.93M	$115.64M
2011-12-31	2.76	$241.63M	$87.44M
2010-12-31	2.04	$139.49M	$68.38M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Keros Therapeutics, Inc. (KROS)	United States	$0.229B	-2.55
Cartesian Therapeutics, Inc. (RNAC)	United States	$0.231B	-2.04
Whitehawk Therapeutics, Inc. (WHWK)	United States	$0.221B
SIGA TECHNOLOGIES INC (SIGA)	United States	$0.234B	-93.33
Eledon Pharmaceuticals, Inc. (ELDN)	United States	$0.219B	-3.23
Sionna Therapeutics, Inc. (SION)	United States	$0.236B	-20.37
Camp4 Therapeutics Corp (CAMP)	United States	$0.240B	-2.12
Foghorn Therapeutics Inc. (FHTX)	United States	$0.213B	-4.43
MACROGENICS INC (MGNX)	United States	$0.242B	-20.11
Cue Biopharma, Inc. (CUE)	United States	$0.243B	-1.01